Reuters insight: Scientists debating risks of accelerated testing for coronavirus vaccine

As pressure for a coronavirus vaccine mounts, Reuters took readers on a deep dive into how drugmakers are working as quickly as possible to develop a vaccine to combat the rapidly spreading virus that has infected more than 100,000 people worldwide. But behind the scenes, scientists and medical experts are concerned that rushing a vaccine could end up worsening the infection in some patients rather than preventing it.